Vident Investment Advisory’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Vident Investment Advisory’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,693	Closed	-$32K	–	497
2023 Q2	$32K	Sell	10,693 -10,136	-49%	-$32.6K	﹤0.01%	1161
2023 Q1	$72.1K	Buy	20,829 +8,500	+69%	+$41.2K	﹤0.01%	1187
2022 Q4	$51.5K	Sell	12,329 -61,529	-83%	-$233K	﹤0.01%	1149
2022 Q3	$287K	Sell	73,858 -3,102	-4%	-$23.5K	0.01%	906
2022 Q2	$867K	Buy	76,960 +48,358	+169%	+$580K	0.03%	669
2022 Q1	$464K	Buy	28,602 +6,608	+30%	+$169K	0.01%	945
2021 Q4	$1.04M	Sell	21,994 -1,072	-5%	-$64.3K	0.03%	690
2021 Q3	$1.67M	Sell	23,066 -2,488	-10%	-$180K	0.05%	510
2021 Q2	$2.15M	Sell	25,554 -22,793	-47%	-$1.5M	0.07%	380
2021 Q1	$2.34M	Sell	48,347 -4,203	-8%	-$228K	0.08%	300
2020 Q4	$2.48M	Buy	52,550 +44,059	+519%	+$1.73M	0.1%	207
2020 Q3	$399K	Sell	8,491 -7,025	-45%	-$232K	0.02%	715
2020 Q2	$464K	Sell	15,516 -4,306	-22%	-$89.1K	0.02%	667
2020 Q1	$258K	Buy	+19,822	New	+$248K	0.02%	710

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Vident Investment Advisory's NBP Position: Q3 2023 in Review

Vident Investment Advisory sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2023, closing a stake of 10,693 shares — an estimated $32K sold.

Vident Investment Advisory first reported a position in NBP in Q1 2020 and held it in 14 quarters. The position peaked at $2.48M in Q4 2020. 47 funds tracked by Wall St. Rank hold NBP as of Q3 2023.

Vident Investment Advisory reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2023 after selling out during the quarter.
Vident Investment Advisory sold 10,693 NovaBridge Biosciences American Depositary Shares shares in Q3 2023, an estimated $32K.
Vident Investment Advisory first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and held it in 14 quarters.
Vident Investment Advisory's NovaBridge Biosciences American Depositary Shares position peaked at $2.48M in Q4 2020.
47 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.